Transgelin interacts with PARP1 in human colon cancer cells.

Background: Transgelin, an actin-binding protein, is associated with cytoskeleton remodeling. Findings from our previous studies demonstrated that transgelin was up-regulated in node-positive colorectal cancer (CRC) versus node-negative disease. Over-expression of affected the expression of 256 downstream transcripts and increased the metastatic potential of colon cancer cells in vitro and in vivo.